NCT05450757

Shanghai ST-segment Elevation Myocardial Infarction Cohort

A Prospective Multicentre Cohort Study of Acute ST-segment Elevation Myocardial Infarction

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

ST-segment elevation myocardial infarction(STEMI) remains a major cause of morbidity and mortality worldwide, despite of the early reperfusion therapy, including fibrinolysis, primary percutaneous coronary intervention (PCI),and standardized medical treatment.To improve the prognosis of STEMI patients, the management in their hospitalization should be optimized, including improvements in risk stratification, more widespread use of an invasive strategy, implementation of care delivery systems prioritising immediate revascularisation through PCI (or fibrinolysis), advances in antiplatelet agents and anticoagulants, and greater use of secondary prevention strategies such as lipid-lowering therapy. This study aims to standardized the management of STEMI patients and improve the prognosis of the STEMI patients.

Detailed description

This study is a prospective cohort study. It aims to standardized the management of STEMI patients and improve the prognosis of the STEMI patients.

Conditions

• ST Elevation Myocardial Infarction

Timeline

• Start date: 2018-09-12
• Primary completion: 2023-09-17
• Completion: 2024-09-17
• First posted: 2022-07-11
• Last updated: 2022-07-11

Locations

7 sites across 1 country: China